CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease

European Journal of Clinical Investigation

Volumn 39, Issue 1, 2009, Pages 17-22

  Bulut, D ^a   Tuns H ^a   Mugge A ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Endothelial dysfunction; Endothelial microparticles; Endothelial progenitor cells

Indexed keywords

C REACTIVE PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; LIPOCORTIN 5; VASCULOTROPIN RECEPTOR 2;

ADULT; APOPTOSIS; ARTICLE; CELL DAMAGE; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; FAMILY HISTORY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGENY; STEM CELL;

ADULT; ANNEXIN A5; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 57649143106     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.02058.x     Document Type: Article

References (29)

1. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990 323 : 27 36.
2. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993 87 : 1468 74.
3. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993 92 : 652 62.
4. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996 27 : 567 74.
5. Clarkson P, Celermajer DS, Pwoe AJ, Donald AE, Henry RM, Deanfield JE. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 1997 96 : 3378 83.
6. Schächinger V, Britten MB, Elsner M, Walter DH, Scharrer I, Zeiher AM. A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation. Circulation 1999 100 : 1502 8.
7. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005 45 : 321 5.
8. Andreou I, Tousoulis D, Tentolouris C, Antoniades C, Stefanadis C. Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives. Atherosclerosis 2006 189 : 247 54.
9. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004 9 : 1118 35.
10. Khan SS, Solomon MA, McKoy JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry Part B (Clin Cytometry) 2005 64B : 1 8.
11. Bulut D, Albrecht N, Imöhl M, Günesdogan B, Bulut-Streich N, Börgel J et al. Hormonal status modulates circulating endothelial progenitor cells. Clin Res Cardiol 2007 96 : 258 63.
12. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005 111 : 2981 7.
13. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006 26 : 112 6.
14. Taddei S, Virdis A, Mattei P, Arzilli F, Salvetti A. Endothelium- dependent forearm vasodilation is reduced in normotensive subjects with a familial history of hypertension. J Cardiovasc Pharmacol 1992 20 (Suppl. 12 S193 5.
15. Zizek B, Poredos P, Videcnik V. Endothelial dysfunction in hypertensive patients and normotensive offspring of subjects with essential hypertension. Heart 2001 85 : 215 7.
16. Goldfine AB, Beckman JA, Betensky RA, Devlin H, Hurley S, Varo N et al. Family history of diabetes is a major determinant of endothelial function. J Am Coll Cardiol 2006 47 : 456 61.
17. Schlaich MP, Parnell MM, Ahlers BA, Finch S, Marshall T, Zhang WZ et al. Impaired 1-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation 2004 110 : 3680 6.
18. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000 101 : 1780 4.
19. Hamburg NM, Charbonneau F, Gerhard-Herman M, Ganz P, Creager MA. Comparison of endothelial function in young men and women with a family history of premature coronary artery disease. Am J Cardiol 2004 94 : 783 5.
20. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Bidot CJ, Ahn YS. Endothelial microparticles (EMP) as vascular disease markers. Adv Clin Chem 2005 39 : 131 57.
21. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles. A potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006 48 : 180 6.
22. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005 288 : H1004 9.
23. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology and possible clinical relevance. J Cell Mol Med 2004 8 : 498 508.
24. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001 89 : E1 7.
25. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 348 : 593 600.
26. Güven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006 48 : 1579 87.
27. Whittaker A, Moore JS, Vasa-Nicotera M, Stevens S, Samani NJ. Evidence for genetic regulation of endothelial progenitor cells and their role as biological markers of atherosclerotic susceptibility. Eur Heart J 2008 29 : 332 8.
28. Murabito JM, Nam BH, D'Agostino RB, Lloyd-Jones D, O'Donnell CJ, Wilson WF. Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med 2004 140 : 434 40.
29. Mannucci PM. Von Willebrand factor. A marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998 18 : 1359 62.